Transforming growth factor-beta (TGF-β), a well-known morphogen ... of Sciences revealed the molecular mechanism of TGF-β ...

Significantly higher levels of the miRNA molecule miR-3591-5p were seen in those with CHD and moderate to severe PAH than ...

Targeting the TSP-1/latent TGF-beta pathway represents a disease-context specific approach to controlling inappropriate TGF-beta activity, while sparing the necessary, beneficial levels of TGF-beta ...

For the first time, researchers have discovered that the accumulation of aged and failing cells, called senescent cells, in ...

Dysfunctional TGF-Beta is a major contributor to lung diseases ... in 2016 to develop therapeutics for targets in the Wnt pathway, a key signaling pathway that is involved in embryo development ...

Spine BioPharma, Inc., a development stage company committed to non-opiate, non-surgical therapies for Degenerative Disc ...

The transforming growth factor beta (TGF-beta) pathway regulates vascular remodeling and mutations in its receptor genes, TGFBR1 and TGFBR2, cause syndromes with thoracic aortic aneurysm (TAA).

Jefferies initiated coverage of Keros Therapeutics (KROS) with a Buy rating and $107 price target The firm says Keros has expertise in the ...

Transforming growth factor-beta (TGF-β), a well-known morphogen ... "Given the high conservation of TGF-β signaling, manipulating TGF-β pathways to coordinate mitochondrial stress responses ...

Jefferies initiated coverage of Keros Therapeutics (KROS) with a Buy rating and $107 price target The firm says Keros has expertise in the TGF-beta pathway, which plays roles in blood, lung and ...